黄斑-话题@MedSci

#黄斑#

154篇内容 | 1395人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1525051, encodeId=96e2152505135, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=拜耳Eylea 2个III期糖尿病性黄斑水肿试验均达主要终点, objectType=article, longId=22742, objectId=237922e4273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=237922e4273, replyNumber=0, likeNumber=50, createdTime=2013-08-09, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=237922e4273, moduleTitle=拜耳Eylea 2个III期糖尿病性黄斑水肿试验均达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=237922e4273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525050, encodeId=0dcc1525050a7, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=CHMP建议批准拜耳Eylea用于视网膜中央静脉阻塞(CRVO)继发黄斑水肿（ME）, objectType=article, longId=22426, objectId=41c4224261a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41c4224261a, replyNumber=0, likeNumber=34, createdTime=2013-08-02, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41c4224261a, moduleTitle=CHMP建议批准拜耳Eylea用于视网膜中央静脉阻塞(CRVO)继发黄斑水肿（ME）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41c4224261a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525049, encodeId=fd64152504975, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Hum Mol Genet：iPS可以作为遗传性黄斑变性的新型干细胞模型, objectType=article, longId=18213, objectId=efdb18213aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efdb18213aa, replyNumber=0, likeNumber=34, createdTime=2013-05-08, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efdb18213aa, moduleTitle=Hum Mol Genet：iPS可以作为遗传性黄斑变性的新型干细胞模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efdb18213aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525048, encodeId=372215250483d, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Neurology：芬戈莫德治疗多发性硬化可增黄斑体积, objectType=article, longId=13869, objectId=f1af13869e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1af13869e1, replyNumber=0, likeNumber=38, createdTime=2012-12-30, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1af13869e1, moduleTitle=Neurology：芬戈莫德治疗多发性硬化可增黄斑体积, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1af13869e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525047, encodeId=a621152504e3e, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=JAMA：长期服用阿司匹林与年龄相关的黄斑变性风险增加有关, objectType=article, longId=13475, objectId=fd54134e56b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd54134e56b, replyNumber=0, likeNumber=41, createdTime=2012-12-22, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd54134e56b, moduleTitle=JAMA：长期服用阿司匹林与年龄相关的黄斑变性风险增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd54134e56b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525046, encodeId=8208152504672, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Diabetes Care:微动脉瘤更替预测临床意义黄斑水肿, objectType=article, longId=12939, objectId=38c41293999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38c41293999, replyNumber=0, likeNumber=0, createdTime=2012-12-14, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38c41293999, moduleTitle=Diabetes Care:微动脉瘤更替预测临床意义黄斑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38c41293999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525045, encodeId=e3de1525045d9, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异, objectType=article, longId=9014, objectId=b7e790149f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7e790149f, replyNumber=0, likeNumber=37, createdTime=2012-08-17, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7e790149f, moduleTitle=BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7e790149f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525044, encodeId=acfa152504471, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=FDA推荐雷珠单抗治疗糖尿病黄斑水肿, objectType=article, longId=8616, objectId=88d586166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88d586166c, replyNumber=0, likeNumber=39, createdTime=2012-08-08, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88d586166c, moduleTitle=FDA推荐雷珠单抗治疗糖尿病黄斑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88d586166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525043, encodeId=e8cf152504332, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Ophthalmology：维生素C和E无法防止黄斑变性, objectType=article, longId=6144, objectId=bf8a614489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf8a614489, replyNumber=0, likeNumber=41, createdTime=2012-05-12, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf8a614489, moduleTitle=Ophthalmology：维生素C和E无法防止黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf8a614489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525042, encodeId=6d1b152504209, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=糖尿病性黄斑水肿治疗新药Optina中期试验审查结束, objectType=article, longId=5755, objectId=0bd45e555c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bd45e555c, replyNumber=0, likeNumber=50, createdTime=2012-04-27, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bd45e555c, moduleTitle=糖尿病性黄斑水肿治疗新药Optina中期试验审查结束, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bd45e555c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525041, encodeId=44ea1525041ca, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Ophthalmology：兰尼单抗治疗黄斑水肿不能快速起效, objectType=article, longId=4125, objectId=cd564125ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd564125ba, replyNumber=0, likeNumber=40, createdTime=2012-02-26, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd564125ba, moduleTitle=Ophthalmology：兰尼单抗治疗黄斑水肿不能快速起效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd564125ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525040, encodeId=9c63152504054, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=FDA批准干性黄斑变性神经干细胞疗法的临床试验, objectType=article, longId=3957, objectId=3ad0395ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ad0395ee8, replyNumber=0, likeNumber=39, createdTime=2012-02-13, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ad0395ee8, moduleTitle=FDA批准干性黄斑变性神经干细胞疗法的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ad0395ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525039, encodeId=591d152503960, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Lancet: 干细胞治疗黄斑变性取得初步成效, objectType=article, longId=3777, objectId=f90b3e77db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f90b3e77db, replyNumber=0, likeNumber=33, createdTime=2012-01-27, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f90b3e77db, moduleTitle=Lancet: 干细胞治疗黄斑变性取得初步成效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f90b3e77db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525038, encodeId=a798152503832, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=FDA批准阿柏西普治疗老年黄斑变性, objectType=article, longId=3355, objectId=138133553e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=138133553e, replyNumber=0, likeNumber=35, createdTime=2011-11-30, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=138133553e, moduleTitle=FDA批准阿柏西普治疗老年黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=138133553e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

黄斑

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

拜耳Eylea 2个III期糖尿病性黄斑水肿试验均达主要终点

2013-08-09

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

CHMP建议批准拜耳Eylea用于视网膜中央静脉阻塞(CRVO)继发黄斑水肿（ME）

2013-08-02

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Hum Mol Genet：iPS可以作为遗传性黄斑变性的新型干细胞模型

2013-05-08

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Neurology：芬戈莫德治疗多发性硬化可增黄斑体积

2012-12-30

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

JAMA：长期服用阿司匹林与年龄相关的黄斑变性风险增加有关

2012-12-22

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Diabetes Care:微动脉瘤更替预测临床意义黄斑水肿

2012-12-14

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异

2012-08-17

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

FDA推荐雷珠单抗治疗糖尿病黄斑水肿

2012-08-08

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Ophthalmology：维生素C和E无法防止黄斑变性

2012-05-12

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

糖尿病性黄斑水肿治疗新药Optina中期试验审查结束

2012-04-27

heli0118 (审核中...)

前往app查看评论内容

#黄斑#

Ophthalmology：兰尼单抗治疗黄斑水肿不能快速起效

2012-02-26

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

FDA批准干性黄斑变性神经干细胞疗法的临床试验

2012-02-13

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Lancet: 干细胞治疗黄斑变性取得初步成效

2012-01-27

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

FDA批准阿柏西普治疗老年黄斑变性

2011-11-30

科室
- - 订阅+
  - 更多科室
工具
服务